BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 14707061)

  • 1. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.
    Campbell KS; Yusa S; Kikuchi-Maki A; Catina TL
    J Immunol; 2004 Jan; 172(2):899-906. PubMed ID: 14707061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.
    Kikuchi-Maki A; Yusa S; Catina TL; Campbell KS
    J Immunol; 2003 Oct; 171(7):3415-25. PubMed ID: 14500636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
    Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
    Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
    Faure M; Long EO
    J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.
    Cantoni C; Bottino C; Vitale M; Pessino A; Augugliaro R; Malaspina A; Parolini S; Moretta L; Moretta A; Biassoni R
    J Exp Med; 1999 Mar; 189(5):787-96. PubMed ID: 10049942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
    Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
    J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
    Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
    J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
    Smith KM; Wu J; Bakker AB; Phillips JH; Lanier LL
    J Immunol; 1998 Jul; 161(1):7-10. PubMed ID: 9647200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cross-talk among natural cytotoxicity receptors in human natural killer cells.
    Augugliaro R; Parolini S; Castriconi R; Marcenaro E; Cantoni C; Nanni M; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 2003 May; 33(5):1235-41. PubMed ID: 12731048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.
    Saether PC; Hoelsbrekken SE; Fossum S; Dissen E
    J Immunol; 2011 Dec; 187(12):6365-73. PubMed ID: 22084441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning, gene structure, and expression pattern of pig immunoreceptor DAP12.
    Yim D; Jie HB; Lanier LL; Kim YB
    Immunogenetics; 2000 May; 51(6):436-42. PubMed ID: 10866110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.
    Vitale M; Bottino C; Sivori S; Sanseverino L; Castriconi R; Marcenaro E; Augugliaro R; Moretta L; Moretta A
    J Exp Med; 1998 Jun; 187(12):2065-72. PubMed ID: 9625766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.
    Terme M; Tomasello E; Maruyama K; Crépineau F; Chaput N; Flament C; Marolleau JP; Angevin E; Wagner EF; Salomon B; Lemonnier FA; Wakasugi H; Colonna M; Vivier E; Zitvogel L
    J Immunol; 2004 May; 172(10):5957-66. PubMed ID: 15128777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs of human leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment.
    Verbrugge A; Ruiter Td Td; Clevers H; Meyaard L
    Int Immunol; 2003 Nov; 15(11):1349-58. PubMed ID: 14565933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human NKG2F is expressed and can associate with DAP12.
    Kim DK; Kabat J; Borrego F; Sanni TB; You CH; Coligan JE
    Mol Immunol; 2004 May; 41(1):53-62. PubMed ID: 15140575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.